Imagene AI For Profit
Imagene provides AI-based molecular testing for cancer, detecting in real-time, a broad range of cancerous biomarkers from the biopsy image
Technology:
AI-driven
Headquarters:
Tel Aviv, Tel Aviv, Israel
Funding Status:
Early Stage Venture
Founded Date:
1905-07-12
Last Funding Type:
Series A
Investors Number:
4
Last Funding Date:
2022-05-02
Estimated Revenue:
Israel"
Employee Number:
Tel Aviv, Tel Aviv, Israel
Total Funding:
21500000
Industry:
Deep Diagnostics